Caspofungin versus liposomal amphotericin B for empirical therapy.
Schneemann
Markus
M
Imhof
Alexander
A
D000666:Amphotericin B / Q000008:administration & dosage* / Q000191:economics / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000191:economics / Q000627:therapeutic use*; D000077336:Caspofungin; D003840:Deoxycholic Acid / Q000008:administration & dosage* / Q000191:economics; D004338:Drug Combinations; D054714:Echinocandins; D005334:Fever / Q000209:etiology; D006801:Humans; D007262:Infusions, Intravenous; D055666:Lipopeptides; D009181:Mycoses / Q000188:drug therapy*; D009503:Neutropenia / Q000209:etiology; D010456:Peptides, Cyclic / Q000627:therapeutic use*
D000935:Antifungal Agents; D004338:Drug Combinations; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; D003840:Deoxycholic Acid; D000666:Amphotericin B; C059765:amphotericin B, deoxycholate drug combination; D000077336:Caspofungin